Status:
COMPLETED
Impact of COVID-19 Infection on the Incidence of Ventilator-acquired Infections
Lead Sponsor:
University Hospital, Lille
Conditions:
SARS-CoV 2
Eligibility:
All Genders
18+ years
Brief Summary
Observational cohort study aiming at comparing the incidence of ventilator-associated lower respiratory tract infections between COVID-19 patients and two control groups: one with influenza pneumonia ...
Detailed Description
COVAPID is a multicenter cohort study with two retrospective control groups. No intervention will be performed in included patients, only patient characteristics and data on VA-LRTI will be collected....
Eligibility Criteria
Inclusion
- For all three groups:
- Major patient
- In patients in ICU
- Patients intubated and mechanically ventilated for more than 48 hours.
- For the SARS-CoV2 group: community-acquired SARS-CoV2 pneumonia For the influenza group: community-acquired influenza pneumonia For the "No Viral Infection" group: no viral pneumonia on admission.
Exclusion
- Refusal to participate
- Lack of social security coverage
Key Trial Info
Start Date :
April 22 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2020
Estimated Enrollment :
1576 Patients enrolled
Trial Details
Trial ID
NCT04359693
Start Date
April 22 2020
End Date
July 1 2020
Last Update
July 22 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital Roger Salengro, ICU, CHU Lille
Lille, France, 59037